Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Jul;88(1):310–314. doi: 10.1172/JCI115293

Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells.

T E Bunchman 1, C A Brookshire 1
PMCID: PMC296034  PMID: 2056124

Abstract

Endothelin (ET), a peptide synthesized by endothelial cells (EC), causes a decreased renal blood flow and glomerular filtration rate and an increased mean arterial pressure when infused in animals. In tissue culture, ET causes smooth muscle cell (SMC) proliferation and contraction by influx of extracellular calcium, which is inhibited by calcium channel antagonists. Infusion of cyclosporine (CSA) hemodynamically parallels ET action, and knowing that CSA effects EC, we hypothesize that the vasoconstrictive effects of CSA are a result of ET synthesis by EC. Varying concentrations of CSA were incubated with EC resulting in ET present in the supernatants in a dose-dependent manner peaking at 75% above basal activity. Coincubation of either cremophor alone or cycloheximide with CSA resulted in minimal ET present in the EC supernatants (P less than 0.01 each). Incubation of conditioned media from CSA-treated EC with SMC caused proliferation at 114% above basal activity, which did not occur in the presence of CSA alone (P less than 0.01). This activity is specifically inhibited in the presence of an anti-ET antibody or nonspecifically in the presence of calcium channel antagonists (P less than 0.01 each). Therefore, CSA stimulates EC synthesis of ET which in turn causes SMC proliferation. This action is inhibited by the coincubation of a specific antibody to ET or a calcium channel antagonist. These findings may help in the understanding of CSA-induced hypertension and vasculopathy.

Full text

PDF
310

Images in this article

312Image
on p.312

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Badr K. F., Murray J. J., Breyer M. D., Takahashi K., Inagami T., Harris R. C. Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. J Clin Invest. 1989 Jan;83(1):336–342. doi: 10.1172/JCI113880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brenner B. M., Troy J. L., Ballermann B. J. Endothelium-dependent vascular responses. Mediators and mechanisms. J Clin Invest. 1989 Nov;84(5):1373–1378. doi: 10.1172/JCI114309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brown Z., Neild G. H. Cyclosporine inhibits prostacyclin production by cultured human endothelial cells. Transplant Proc. 1987 Feb;19(1 Pt 2):1178–1180. [PubMed] [Google Scholar]
  4. Brown Z., Neild G. H., Lewis G. P. Mechanism of inhibition of prostacyclin synthesis by cyclosporine in cultured human umbilical vein endothelial cells. Transplant Proc. 1988 Jun;20(3 Suppl 3):654–657. [PubMed] [Google Scholar]
  5. Brown Z., Neild G. H., Willoughby J. J., Somia N. V., Cameron S. J. Increased factor VIII as an index of vascular injury in cyclosporine nephrotoxicity. Transplantation. 1986 Aug;42(2):150–153. doi: 10.1097/00007890-198608000-00009. [DOI] [PubMed] [Google Scholar]
  6. Bunchman T. E., Brookshire C. A. Cyclosporine inhibition of adherence proteins and factor VIII of vascular endothelium. Transplant Proc. 1991 Feb;23(1 Pt 1):332–333. [PubMed] [Google Scholar]
  7. Bunchman T. E., Mauer S. M., Kim Y. Effect of cyclosporin on generalized Shwartzman reaction in diabetic rats. Diabetes. 1990 Jan;39(1):83–86. doi: 10.2337/diacare.39.1.83. [DOI] [PubMed] [Google Scholar]
  8. Cairns H. S., Rogerson M., Fairbanks L. D., Westwick J., Neild G. H. Endothelin and cyclosporin nephrotoxicity. Lancet. 1988 Dec 24;2(8626-8627):1496–1497. doi: 10.1016/s0140-6736(88)90978-6. [DOI] [PubMed] [Google Scholar]
  9. Chabrier P. E., Auguet M., Roubert P., Lonchampt M. O., Gillard V., Guillon J. M., Delaflotte S., Braquet P. Vascular mechanism of action of endothelin-1: effect of Ca2+ antagonists. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S32–S45. doi: 10.1097/00005344-198900135-00009. [DOI] [PubMed] [Google Scholar]
  10. Clozel M., Fischli W., Guilly C. Specific binding of endothelin on human vascular smooth muscle cells in culture. J Clin Invest. 1989 May;83(5):1758–1761. doi: 10.1172/JCI114078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Clozel M., Fischli W. Human cultured endothelial cells do secrete endothelin-1. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S229–S231. doi: 10.1097/00005344-198900135-00068. [DOI] [PubMed] [Google Scholar]
  12. Cohen D. J., Loertscher R., Rubin M. F., Tilney N. L., Carpenter C. B., Strom T. B. Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med. 1984 Nov;101(5):667–682. doi: 10.7326/0003-4819-101-5-667. [DOI] [PubMed] [Google Scholar]
  13. Dy G. R., Raja R. M., Mendez M. M. The clinical and biochemical effect of calcium channel blockers in organ transplant recipients on cyclosporine. Transplant Proc. 1991 Feb;23(1 Pt 2):1258–1259. [PubMed] [Google Scholar]
  14. English J., Evan A., Houghton D. C., Bennett W. M. Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation. 1987 Jul;44(1):135–141. doi: 10.1097/00007890-198707000-00027. [DOI] [PubMed] [Google Scholar]
  15. Firth J. D., Ratcliffe P. J., Raine A. E., Ledingham J. G. Endothelin: an important factor in acute renal failure? Lancet. 1988 Nov 19;2(8621):1179–1182. doi: 10.1016/s0140-6736(88)90243-7. [DOI] [PubMed] [Google Scholar]
  16. Goetz K. L., Wang B. C., Madwed J. B., Zhu J. L., Leadley R. J., Jr Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol. 1988 Dec;255(6 Pt 2):R1064–R1068. doi: 10.1152/ajpregu.1988.255.6.R1064. [DOI] [PubMed] [Google Scholar]
  17. Harlan J. M., Harker L. A., Reidy M. A., Gajdusek C. M., Schwartz S. M., Striker G. E. Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest. 1983 Mar;48(3):269–274. [PubMed] [Google Scholar]
  18. Harlan J. M., Harker L. A., Striker G. E., Weaver L. J. Effects of lipopolysaccharide on human endothelial cells in culture. Thromb Res. 1983 Jan 1;29(1):15–26. doi: 10.1016/0049-3848(83)90121-4. [DOI] [PubMed] [Google Scholar]
  19. Highsmith R. F., Pang D. C., Rapoport R. M. Endothelial cell-derived vasoconstrictors: mechanisms of action in vascular smooth muscle. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S36–S45. [PubMed] [Google Scholar]
  20. Hirata Y., Yoshimi H., Takata S., Watanabe T. X., Kumagai S., Nakajima K., Sakakibara S. Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1988 Aug 15;154(3):868–875. doi: 10.1016/0006-291x(88)90220-3. [DOI] [PubMed] [Google Scholar]
  21. Ishikawa T., Yanagisawa M., Kimura S., Goto K., Masaki T. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am J Physiol. 1988 Oct;255(4 Pt 2):H970–H973. doi: 10.1152/ajpheart.1988.255.4.H970. [DOI] [PubMed] [Google Scholar]
  22. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973 Nov;52(11):2745–2756. doi: 10.1172/JCI107470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Komuro I., Kurihara H., Sugiyama T., Yoshizumi M., Takaku F., Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett. 1988 Oct 10;238(2):249–252. doi: 10.1016/0014-5793(88)80489-7. [DOI] [PubMed] [Google Scholar]
  24. Kon V., Yoshioka T., Fogo A., Ichikawa I. Glomerular actions of endothelin in vivo. J Clin Invest. 1989 May;83(5):1762–1767. doi: 10.1172/JCI114079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Korb S., Albornoz G., Brems W., Ali A., Light J. A. Verapamil pretreatment of hemodynamically unstable donors prevents delayed graft function post-transplant. Transplant Proc. 1989 Feb;21(1 Pt 2):1236–1238. [PubMed] [Google Scholar]
  26. Marsden P. A., Danthuluri N. R., Brenner B. M., Ballermann B. J., Brock T. A. Endothelin action on vascular smooth muscle involves inositol trisphosphate and calcium mobilization. Biochem Biophys Res Commun. 1989 Jan 16;158(1):86–93. doi: 10.1016/s0006-291x(89)80180-9. [DOI] [PubMed] [Google Scholar]
  27. Murray B. M., Paller M. S., Ferris T. F. Effect of cyclosporine administration on renal hemodynamics in conscious rats. Kidney Int. 1985 Nov;28(5):767–774. doi: 10.1038/ki.1985.196. [DOI] [PubMed] [Google Scholar]
  28. Myers B. D., Ross J., Newton L., Luetscher J., Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med. 1984 Sep 13;311(11):699–705. doi: 10.1056/NEJM198409133111103. [DOI] [PubMed] [Google Scholar]
  29. Nayler W. G., Gu X. H., Casley D. J., Panagiotopoulos S., Liu J., Mottram P. L. Cyclosporine increases endothelin-1 binding site density in cardiac cell membranes. Biochem Biophys Res Commun. 1989 Sep 29;163(3):1270–1274. doi: 10.1016/0006-291x(89)91115-7. [DOI] [PubMed] [Google Scholar]
  30. Neild G. H., Rocchi G., Imberti L., Fumagalli F., Brown Z., Remuzzi G., Williams D. G. Effect of Cyclosporin A on prostacyclin synthesis by vascular tissue. Thromb Res. 1983 Nov 15;32(4):373–379. doi: 10.1016/0049-3848(83)90090-7. [DOI] [PubMed] [Google Scholar]
  31. Orita Y., Fujiwara Y., Ochi S., Takama T., Fukunaga M., Yokoyama K. Endothelin-1 receptors in rat renal glomeruli. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S159–S161. doi: 10.1097/00005344-198900135-00043. [DOI] [PubMed] [Google Scholar]
  32. Perico N., Dadan J., Remuzzi G. Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat. J Am Soc Nephrol. 1990 Jul;1(1):76–83. [PubMed] [Google Scholar]
  33. Simonson M. S., Dunn M. J. Endothelin-1 stimulates contraction of rat glomerular mesangial cells and potentiates beta-adrenergic-mediated cyclic adenosine monophosphate accumulation. J Clin Invest. 1990 Mar;85(3):790–797. doi: 10.1172/JCI114505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Simonson M. S., Wann S., Mené P., Dubyak G. R., Kester M., Dunn M. J. Endothelin-1 activates the phosphoinositide cascade in cultured glomerular mesangial cells. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S80–S84. doi: 10.1097/00005344-198900135-00019. [DOI] [PubMed] [Google Scholar]
  35. Sobh M. A., Shehab el-Din A. B., Moustafa F. E., el-Far M. A., Hussein M. E., Gad H. M., Ghoneim M. A. A prospective randomized study of the protective effect of verapamil on ischemic renal injury in renal allotransplants. Transplant Proc. 1989 Feb;21(1 Pt 2):1230–1232. [PubMed] [Google Scholar]
  36. Vanrenterghem Y., Roels L., Lerut T., Gruwez J., Michielsen P., Gresele P., Deckmyn H., Colucci M., Arnout J., Vermylen J. Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet. 1985 May 4;1(8436):999–1002. doi: 10.1016/s0140-6736(85)91610-1. [DOI] [PubMed] [Google Scholar]
  37. Voyta J. C., Via D. P., Butterfield C. E., Zetter B. R. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol. 1984 Dec;99(6):2034–2040. doi: 10.1083/jcb.99.6.2034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wallnöfer A., Weir S., Rüegg U., Cauvin C. The mechanism of action of endothelin-1 as compared with other agonists in vascular smooth muscle. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S23–S45. doi: 10.1097/00005344-198900135-00008. [DOI] [PubMed] [Google Scholar]
  39. Yanagisawa M., Inoue A., Ishikawa T., Kasuya Y., Kimura S., Kumagaye S., Nakajima K., Watanabe T. X., Sakakibara S., Goto K. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6964–6967. doi: 10.1073/pnas.85.18.6964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  41. Zoja C., Furci L., Ghilardi F., Zilio P., Benigni A., Remuzzi G. Cyclosporin-induced endothelial cell injury. Lab Invest. 1986 Oct;55(4):455–462. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES